Novo Nordisk IT Security Incident Exposes Limited Patient and HCP Data

**Executive Summary:** Novo Nordisk reported unauthorized access to a limited number of internal IT systems and the external copying of certain non-public data, including pseudonymized clinical trial participant information (e.g., patient ID, biomarkers, year of birth, health data) and healthcare professional contact details; the company has taken affected systems offline, engaged external cybersecurity experts, is notifying impacted individuals, and states business operations remain unaffected.